Insights in the molecular mechanisms of an azole stress adapted laboratory-generated Aspergillus fumigatus strain.

Détails

ID Serval
serval:BIB_B19CC367C75B
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Insights in the molecular mechanisms of an azole stress adapted laboratory-generated Aspergillus fumigatus strain.
Périodique
Medical mycology
Auteur(s)
Aruanno M., Gozel S., Mouyna I., Parker J.E., Bachmann D., Flamant P., Coste A.T., Sanglard D., Lamoth F.
ISSN
1460-2709 (Electronic)
ISSN-L
1369-3786
Statut éditorial
Publié
Date de publication
14/07/2021
Peer-reviewed
Oui
Volume
59
Numéro
8
Pages
763-772
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: ppublish
Résumé
Aspergillus fumigatus is the main cause of invasive aspergillosis, for which azole drugs are the first-line therapy. Emergence of pan-azole resistance among A. fumigatus is concerning and has been mainly attributed to mutations in the target gene (cyp51A). However, azole resistance may also result from other mutations (hmg1, hapE) or other adaptive mechanisms. We performed microevolution experiment exposing an A. fumigatus azole-susceptible strain (Ku80) to sub-minimal inhibitory concentration of voriconazole to analyze emergence of azole resistance. We obtained a strain with pan-azole resistance (Ku80R), which was partially reversible after drug relief, and without mutations in cyp51A, hmg1, and hapE. Transcriptomic analyses revealed overexpression of the transcription factor asg1, several ATP-binding cassette (ABC) and major facilitator superfamily transporters and genes of the ergosterol biosynthesis pathway in Ku80R. Sterol analysis showed a significant decrease of the ergosterol mass under voriconazole exposure in Ku80, but not in Ku80R. However, the proportion of the sterol compounds was similar between both strains. To further assess the role of transporters, we used the ABC transporter inhibitor milbemycine oxime (MLB). MLB inhibited transporter activity in both Ku80 and Ku80R and demonstrated some potentiating effect on azole activity. Criteria for synergism were reached for MLB and posaconazole against Ku80. Finally, deletion of asg1 revealed some role of this transcription factor in controlling drug transporter expression, but had no impact on azole susceptibility.This work provides further insight in mechanisms of azole stress adaptation and suggests that drug transporters inhibition may represent a novel therapeutic target.
A pan-azole-resistant strain was generated in vitro, in which drug transporter overexpression was a major trait. Analyses suggested a role of the transporter inhibitor milbemycin oxime in inhibiting drug transporters and potentiating azole activity.
Mots-clé
efflux pumps, erogsterol, isavuconazole milbemycine, posaconazole, resistance, transporters, voriconazole
Pubmed
Web of science
Création de la notice
22/02/2021 14:37
Dernière modification de la notice
04/09/2021 5:34
Données d'usage